FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2023/05/052605 [Registered on: 12/05/2023] Trial Registered Prospectively
Last Modified On: 30/08/2024
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Drug
Siddha 
Study Design  Single Arm Study 
Public Title of Study   A clinical trial on chitramanakku ilai chooranam in the management of ceganavatham(cervical spondylosis) 
Scientific Title of Study   A PROSPECTIVE OPEN LABELLED SINGLE ARM NON RANDOMIZED SINGLE CENTRIC PHASE II CLINICAL TRIAL ON CHITRAMANAKKU ILAI CHOORANAM IN THE MANAGEMENTOF CEGANAVATHAM(CERVICAL SPONDYLOSIS) 
Trial Acronym   
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr s senthamil veni 
Designation  PG Scholar 
Affiliation  Government Siddha Medical College and Hospital,palayamkottai 
Address  Department of Pothu Maruthuvam, Government Siddha Medical College and Hospital,Palayamkottai, Tirunelveli

Tirunelveli
TAMIL NADU
627002
India 
Phone  8870233762  
Fax    
Email  drveni94@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr S Uma kalyani MDs 
Designation  Lecturer Gr-II 
Affiliation  Government Siddha Medical College and Hospital,Palayamkottai 
Address  PG Department of Pothu Maruthuvam,OP no 10, Government Siddha Medical College and Hospital,Palayamkottai, Tirunelveli

Tirunelveli
TAMIL NADU
627002
India 
Phone  8072685509  
Fax    
Email  sukgsmc2014@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Prof Dr A Manoharan MDs PhD 
Designation  Professor and HOD 
Affiliation  Government Siddha Medical College and Hospital,Palayamkottai,Tirunelveli 
Address  PG Department of Pothu Maruthuvam,OP no 10, Government Siddha Medical College and Hospital,Palayamkottai, Tirunelveli

Tirunelveli
TAMIL NADU
627002
India 
Phone  9443886700  
Fax    
Email  drmanoharan25@gmail.com  
 
Source of Monetary or Material Support  
OPD and IPD facilities and Central Library of Gvernment Siddha Medical College and Hospital 
 
Primary Sponsor  
Name  Government Siddha Medical college and Hospital 
Address  Government Siddha Medical College and Hospital,Palayamkottai,Tirunelveli-627002 Tamilnadu 
Type of Sponsor  Government medical college 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr S Senthamil veni  Government Siddha Medical College and Hospital  PG Department of Pothu Maruthuvam,OP no 10,Government Siddha Medical College and Hospital,Palayamkottai
Tirunelveli
TAMIL NADU 
8870233762

drveni94@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
INSTITUTIONAL ETHICAL COMMITIEE GOVERNMENT SIDDHA MEDICAL COLLEGE, PALAYAMKOTTAI  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: M479||Spondylosis, unspecified,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Intervention  CHITRAMANAKKU ILAI CHOORANAM  2mg Twice a day (orally) Honey/Ghee 45days 
Comparator Agent  NIL  NIL 
 
Inclusion Criteria  
Age From  30.00 Year(s)
Age To  60.00 Year(s)
Gender  Both 
Details  1.Neck pain radiating to upper limb with or without numbness, giddiness and neck stiffness
2.Restriction neck movements.
3.Willing for doing laboratory investigations and X-Ray imaging.
4.The neck disability Index score should be equal or greater than 40%
 
 
ExclusionCriteria 
Details  1.Age : Below 20 Years, Above 60 years
2.Traumatic injury
3.Systemic hypertension
4.Ischemic heart diseases
5.Chronic kidney disease
6.Tuberculosis in spine
7.Secondary malignancy
8.Chronic systemic illness
9.Congenital spinal anomalies  
 
Method of Generating Random Sequence   Not Applicable 
Method of Concealment   Not Applicable 
Blinding/Masking   Open Label 
Primary Outcome  
Outcome  TimePoints 
Reduction of the symptoms of pain in neck and upper limbs
Improvement of the range of movements in the neck and upper limb
The outcome is aimed at reducing pain and increasing the range of movements
Good improvement-score10%below10%
Moderate improvement-score10-20%
Mild improvement-score20-30%
No improvement-score40% 
45 days 
 
Secondary Outcome  
Outcome  TimePoints 
To evaluate the physicochemical,phytochemicals,biochemical analysis of clinical trial drug
To evaluate the safety profile for acute and subacute toxicity of the trial drug
To evaluate Antimicrobial activity of the trial drug
To evaluate the pharmacological analysis of the clinical trial drug
To evaluate siddha parameters and compare the (including envagaithervu)changes in ceganavatham during trial period
To evaluate modern parametric changes in ceganavatham
To evaluate the efficacy of chitramanakku ilai chooranam on ceganavatham by the bio statistical analysis 
45 days 
 
Target Sample Size   Total Sample Size="40"
Sample Size from India="40" 
Final Enrollment numbers achieved (Total)= "40"
Final Enrollment numbers achieved (India)="40" 
Phase of Trial   Phase 2 
Date of First Enrollment (India)   21/05/2023 
Date of Study Completion (India) Date Missing 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) 28/08/2024 
Estimated Duration of Trial   Years="1"
Months="0"
Days="0" 
Recruitment Status of Trial (Global)
Modification(s)  
Not Applicable 
Recruitment Status of Trial (India)  Completed 
Publication Details   NIL 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary   The study is a prospective open labelled single arm non randomized single centric   phase II non randomized clinical study to evaluate the therapeutic efficacy of CHITRAMANAKKU ILAI CHOORANAM in the management of CEGANAVATHAM(CERVICAL SPONDYLOSIS).The trial drug will be administered at the dose of 2mg/twice a day(orally)45 days in 40patients.The trial period of 12 months will be carried out in Government Siddha Medical College and Hospital,palayamkottai,Tirunelveli,Tamilnadu.The primary outcome will be the evaluations of siddha diagnostic parameters,assessment of pharmacological and biochemical parameters of trial drug.In case of any adverse events (AE)noticed and it will be referred to pharmacovigilance department of SCRI. Furthur management of patients will be given in OPD facility. 
Close